Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions.
Sarich TC, Peters G, Berkowitz SD, Misselwitz F, Nessel CC, Burton P, Cook-Bruns N, Lensing AW, Haskell L, Perzborn E, Kubitza D, Moore KT, Jalota S, Weber J, Pan G, Sun X, Westermeier T, Nadel A, Oppenheimer L, DiBattiste PM. Sarich TC, et al. Among authors: perzborn e. Ann N Y Acad Sci. 2013 Jul;1291:42-55. doi: 10.1111/nyas.12136. Epub 2013 May 23. Ann N Y Acad Sci. 2013. PMID: 23701516 Review.
The discovery and development of rivaroxaban.
Misselwitz F, Berkowitz SD, Perzborn E. Misselwitz F, et al. Among authors: perzborn e. Ann N Y Acad Sci. 2011 Mar;1222:64-75. doi: 10.1111/j.1749-6632.2011.05971.x. Ann N Y Acad Sci. 2011. PMID: 21434944 Review.
Rivaroxaban: a new oral factor Xa inhibitor.
Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V. Perzborn E, et al. Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):376-81. doi: 10.1161/ATVBAHA.110.202978. Epub 2010 Feb 5. Arterioscler Thromb Vasc Biol. 2010. PMID: 20139357 Review.
54 results